Letter to the Editor: Cannabis use and transition to psychosis: is interpretation of unpleasant effects a mediating variable?

Thomas Richardson, Michael C. Hughes, Kathryn A. Leech, Shalini RamanPsychological 2014 · DOI · OpenAlex

Introduction

While the association between cannabis use and the onset of psychotic disorders is well-established in epidemiological literature, the specific psychological mechanisms driving this transition remain a subject of significant debate. This is particularly relevant for individuals identified as being at "ultra-high risk" (UHR) for psychosis. This paper provides a theoretical synthesis responding to longitudinal findings by Valmaggia et al. (2014), which noted that while many UHR individuals cease cannabis use due to adverse effects like paranoia, a specific subset continues use despite these "unpleasant" experiences. This subset faces a significantly higher risk of transitioning to a clinical psychotic disorder.

The Problem: The Cognitive Gap in Risk Transition

The central question addressed is why some high-risk users recognize adverse symptoms as drug-induced and stop, while others misinterpret these symptoms and continue toward clinical psychosis. The authors propose that the transition is not merely a biological inevitability but is filtered through a specific cognitive mediating variable: the user's attribution of their experiences.

Theoretical Framework and Methodology

As a theoretical correspondence, this work does not present new experimental data but instead applies established cognitive models of delusions and hallucinations—specifically those developed by Garety et al. (2001) and Freeman et al. (2002)—to existing longitudinal data.

The authors propose a mediation hypothesis, suggesting that the relationship between cannabis use and psychosis is mediated by how an individual interprets acute, drug-induced experiences. This framework moves beyond a purely biological model to include a psychological pivot point that determines the trajectory of the user's mental health.

Key Insights: The Role of Attribution

The Attribution Pivot

The core of the proposed framework lies in the distinction between internal and external attribution. When a user experiences drug-induced paranoia, they face a choice of interpretation:

  • Internal Attribution: Recognizing the paranoia as a direct effect of the substance (e.g., "The drug is making me feel this way"). This typically leads to cessation of use.
  • External Attribution: Dismissing the drug as the cause and instead attributing the experience to external threats (e.g., "People are out to get me"). This is often characterized by statements such as, "I've used cannabis for years and it never made me feel this way before; therefore, this threat must be real."

Escalation via Misinterpretation

In line with cognitive models of psychosis, once an unusual experience is attributed to an external threat, it is likely to escalate. This creates a dangerous feedback loop: because the user does not realize the drug is the source of the distress, they may continue to use—sometimes even attempting to "self-medicate" the very anxiety the drug is producing—thereby exacerbating the symptoms and solidifying delusional thinking.

Developmental Sensitivity

The authors highlight that cannabis use during neurologically sensitive periods, such as adolescence, may make these cognitive misinterpretations more likely to become permanent. Early-onset use may interfere with the development of healthy attributional styles, making the transition to chronic psychosis more probable.

Clinical Implications and Future Directions

The proposed framework suggests that the "self-medication hypothesis" may be insufficient for many high-risk individuals. Instead, the inability to link drug-induced psychotic experiences to the substance itself is what drives continued use and subsequent transition.

Intervention Strategies

This model provides a concrete framework for clinical intervention. Psychological treatments, such as Cognitive Behavioral Therapy (CBT), could be specifically tailored to help UHR individuals correctly attribute drug-induced experiences to the substance rather than external threats. By modifying how users interpret acute intoxication, clinicians may be able to mitigate the risk of transition to a full psychotic disorder.

Future Research

While the mediation hypothesis is theoretically robust, the authors note it requires formal testing through prospective longitudinal studies. Future research should focus on:

  • Empirically measuring attributional styles in cannabis users at high risk for psychosis.
  • Developing and testing interventions aimed at modifying the interpretation of acute cannabis effects.
  • Investigating the long-term psychiatric outcomes of external attribution in early-onset users.

Summary updated

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
BibTeX
@inproceedings{richardson2014letter,
  author = {Thomas Richardson and Michael C. Hughes and Kathryn A. Leech and Shalini Raman},
  title = {{Letter to the Editor: Cannabis use and transition to psychosis: is interpretation of unpleasant effects a mediating variable?}},
  booktitle = {Psychological},
  year = {2014},
  doi = {10.1017/s0033291714001494},
}

Loading related content...

Figure